ARTICLE | Company News
J&J infectious news
June 15, 2015 7:00 AM UTC
Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit expanded a 2012 IP policy to allow access to pediatric formulations of HIV drug Prezista darunavir in resource-limited countries. The company sai...